Exploring potential biomarkers and therapeutic targets of long COVID-associated inflammatory cardiomyopathy
Description
CONCLUSION: Screening of potential biomarkers and therapeutic targets sheds new light on the pathogenesis of long COVID-associated inflammatory cardiomyopathy as well as potential therapeutic approaches. Further clinical studies are needed to explore
